• Setup menu at Appearance » Menus and assign menu to Top Bar Navigation
Tuesday, March 2, 2021
No Result
View All Result
The Hub Press
  • Top News
  • World
  • Politics
  • Business
  • Sports
  • Travel
  • Health
  • News TV
  • Lifestyle
  • Science
  • Entertainment
  • Top News
  • World
  • Politics
  • Business
  • Sports
  • Travel
  • Health
  • News TV
  • Lifestyle
  • Science
  • Entertainment
No Result
View All Result
The Hub Press
No Result
View All Result
Home Top News

Hydroxychloroquine: FDA revokes authorization of drug Trump touted

by Thehub Press
June 15, 2020
in Top News
0
Hydroxychloroquine: FDA revokes authorization of drug Trump touted
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter



After reviewing the current research available on the drugs, the FDA determined that the drugs do not meet “the statutory criteria” for emergency use authorization as they are unlikely to be effective in treating Covid-19 based on the latest scientific evidence, the agency noted on its website on Monday.
“FDA has concluded that, based on this new information and other information discussed in the attached memorandum, it is no longer reasonable to believe that oral formulations of HCQ and CQ may be effective in treating COVID-19, nor is it reasonable to believe that the known and potential benefits of these products outweigh their known and potential risks,” FDA chief scientist Denise Hinton wrote in a letter to Gary Disbrow of the Biomedical Advanced Research and Development Authority (BARDA) on Monday. Hydroxychloroquine and chloroquine have been tied to serious cardiac events as well as other side effects among Covid-19 patients.

“Accordingly, FDA revokes the EUA for emergency use of HCQ and CQ to treat COVID-19,” Hinton wrote in the letter, using abbreviations for hydroxychloroquine and chloroquine. “As of the date of this letter, the oral formulations of HCQ and CQ are no longer authorized by FDA to treat COVID-19.”

Doctors can continue to legally prescribe the drugs off-label, as they can with any drug that’s approved for other conditions. The FDA’s emergency use authorization for hydroxychloroquine and chloroquine was narrow in scope, applying only to hospitalized Covid-19 patients and only to drugs donated to the Strategic National Stockpile.

In an open letter published late last month, FDA commissioner Dr. Stephen Hahn appeared to defend the agency’s decision to issue the authorization.

LISTEN: The Coronavirus: Fact vs. Fiction Podcast

“This decision was based on evaluation of the EUA criteria and the scientific evidence available at that time. We continue to look at the data on hydroxychloroquine and chloroquine and we will make future determinations on these products based on available evidence including ongoing clinical studies,” Hahn said in the letter last month.

The emergency use authorization, or EUA, made it easier for pills donated to the national stockpile to be distributed to coronavirus patients.

Hahn added in the letter that “we also knew it was important to help ensure a stable supply of the drugs for patients with lupus and rheumatoid arthritis given the increased demand.”

In an interview with CNN last month, Hahn also defended his agency’s handling of hydroxychloroquine. He acknowledged the political climate surrounding the drug, but said, “I stand by our decisions because I think they are rooted in science and data, and we’ll continue to reevaluate.”

The World Health Organization said on Monday that it is still reviewing the use of hydroxychloroquine in its Solidarity Trial, a multi-country clinical study of Covid-19 treatment options. The organization had temporarily paused the trial in May due to concerns surrounding the drug’s safety and in order to review its own data, but resumed the program earlier this month.
Trump has been a frequent cheerleader for a combination of hydroxychloroquine and the antibiotic azithromycin as a Covid-19 treatment. He promoted the drugs dozens of times, despite pleas from scientists to let studies decide if the treatment worked or not, and has said he took hydroxychloroquine to prevent being infected with coronavirus.
Despite the warnings from health experts, retail sales of the decades-old drug soared in recent weeks amid the growing public attention on the medication.

This story has been updated to include additional background information.

CNN’s Devan Cole contributed to this report.



CNN

Tags: Hydroxychloroquine: FDA revokes authorization of drug Trump touted - CNNPoliticsPOLITICS
Thehub Press

Thehub Press

Next Post
Three types of laws could reduce gun deaths by more than 10% | Science

Three types of laws could reduce gun deaths by more than 10% | Science

Recommended

No Content Available




  • Top News
  • World
  • Politics
  • Business
  • Sports
  • Travel
  • Health
  • News TV
  • Lifestyle
  • Science
  • Entertainment

© 2019 Thehub.Press

No Result
View All Result
  • Top News
  • World
  • Politics
  • Business
  • Sports
  • Travel
  • Health
  • News TV
  • Lifestyle
  • Science
  • Entertainment

© 2019 Thehub.Press